Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2458 to 2507 of 16578 in total
Value Type: Ranked
Filtered: 1

\def\wcA{0.11111111111111\textwidth}
\def\wcB{0.11111111111111\textwidth}
\def\wcC{0.11111111111111\textwidth}
\def\wcD{0.11111111111111\textwidth}
\def\wcE{0.11111111111111\textwidth}
\def\wcF{0.11111111111111\textwidth}
\def\wcG{0.11111111111111\textwidth}
\def\wcH{0.11111111111111\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
615\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXB9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-b9 (hox-2e) (hox-2.5). [source:swissprot;acc:p17482]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.257\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.132\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05999\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
NHP2L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nhp2-like protein 1 (high mobility group-like nuclear protein 2 homolog 1) ([u4/u6.u5] tri-snrnp 15.5 kda protein) (otk27). [source:swissprot;acc:p55769]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.16\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
199.322\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.838\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
POLE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
241.907\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
229.35\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.557\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
616\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arp2/3 complex 34 kda subunit (p34-arc) (actin-related protein 2/3 complex subunit 2). [source:swissprot;acc:o15144]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.495\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.661\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.834\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
CPA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
177.698\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
190.24\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.542\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HOXA9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-a9 (hox-1g). [source:swissprot;acc:p31269]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.257\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.132\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05999\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SURF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
surfeit locus protein 1. [source:swissprot;acc:q15526]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.211\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
195.459\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02943\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
617\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
177.698\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
190.239\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.541\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HOXC9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-c9 (hox-3b). [source:swissprot;acc:p31274]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.257\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.135\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05997\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.235\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
201.402\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.833\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZMPSTE24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
203.738\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.913\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02943\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
618\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
177.699\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
190.24\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.541\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GRB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.479\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.65\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.829\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
205.472\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
199.6\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02942\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
619\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
FOXG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
VPS39\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vam6/vps39-like protein (hvam6p). [source:swissprot;acc:q96jc1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.274\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
218.792\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.518\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
WDFY3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wd repeat and fyve domain containing 3 isoform 1. [source:refseq;acc:nm\_014991]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.129\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
199.271\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0294\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZMPSTE24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
203.738\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
197.913\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.825\vspace{3pt}}\\\cline{1-4}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
620\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
sterol regulatory element binding protein-2 (srebp-2) (sterol regulatory element-binding transcription factor 2). [source:swissprot;acc:q12772]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
203.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
197.868\vspace{3pt}}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02937\vspace{3pt}}\\\cline{4-4}\cline{8-8}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&&\parbox{\wcH}{\vspace{3pt}\noindent
5.812\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated protein 4 (map 4). [source:swissprot;acc:p27816]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.274\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
218.792\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.518\vspace{3pt}}\\\cline{1-4}\cline{6-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
621\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
RPLP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s acidic ribosomal protein p2. [source:swissprot;acc:p05387]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
231.92\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
244.435\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.515\vspace{3pt}}\\\cline{2-8}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
SREBF1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
sterol regulatory element binding protein-1 (srebp-1) (sterol regulatory element-binding transcription factor 1). [source:swissprot;acc:p36956]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
203.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
197.868\vspace{3pt}}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02937\vspace{3pt}}\\\cline{4-4}\cline{8-8}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&&\parbox{\wcH}{\vspace{3pt}\noindent
5.812\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
622\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GRB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.479\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.65\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02934\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
RBM19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable rna-binding protein kiaa0682. [source:swissprot;acc:q9y4c8]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
206.001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
200.193\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.808\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
SYN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcH}{\vspace{3pt}\noindent
12.496\vspace{3pt}}}\\\cline{1-3}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
623\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&&\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
JARID2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
jumonji protein. [source:swissprot;acc:q92833]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.726\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
201.813\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.0293\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
P4HB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
204.369\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.564\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.805\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
624\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HEY1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.496\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
NHP2L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nhp2-like protein 1 (high mobility group-like nuclear protein 2 homolog 1) ([u4/u6.u5] tri-snrnp 15.5 kda protein) (otk27). [source:swissprot;acc:p55769]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.16\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
199.322\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02929\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
P4HA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-1 subunit precursor (ec 1.14.11.2) (4-ph alpha-1) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-1 subunit). [source:swissprot;acc:p13674]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
204.369\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.564\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.805\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
625\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABLIM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.496\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
CUL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.853\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.057\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02926\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
GABRA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
P4HA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-2 subunit precursor (ec 1.14.11.2) (4-ph alpha-2) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-2 subunit). [source:swissprot;acc:o15460]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.369\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.564\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.805\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
626\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GABRE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
HEYL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
12.496\vspace{3pt}}\\\cline{2-8}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
HIST3H3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
histone h3.4 (h3t) (h3/t) (h3/g). [source:swissprot;acc:q16695]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
204.239\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
198.436\vspace{3pt}}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02924\vspace{3pt}}\\\cline{4-4}\cline{8-8}
&&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&&\parbox{\wcH}{\vspace{3pt}\noindent
5.803\vspace{3pt}}\\\cline{1-3}\cline{6-8}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
627\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h3.1 (h3/a) (h3/c) (h3/d) (h3/f) (h3/h) (h3/i) (h3/j) (h3/k) (h3/l). [source:swissprot;acc:p16106]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
204.234\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.433\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.801\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
JMJD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
P4HB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.369\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.564\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.02923\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/